IFM Therapeutics
Small molecule therapeutics targeting innate immune pathways
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2015
- Latest Form D
- $17.1M, Jun 2016
- Total capital
- $17.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $17.1M
- 1 Form D · last Jun 2016
- 124 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 20 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$17.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Gary GlickExecutive Officer, DirectorNamed in SEC Form D filings
- Jean-Francois FormelaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 20- PendingImmune Cells Having Increased Immunity Or Resistance To An Immunosuppressive Cytokine And Use Of The SameUSPTOApplication 15253215
- PendingCompounds And Compositions For Treating Conditions Associated With Sting ActivityUSPTOApplication PCTUS2017049680
- PendingCompounds And Compositions For Treating Conditions Associated With Nlrp ActivityUSPTOApplication 62536352
Show all 20 patent records
- Immune Cells Having Increased Immunity Or Resistance To An Immunosuppressive Cytokine And Use Of The SameMar 2, 2017 · Application 15253215Pending
- Compounds And Compositions For Treating Conditions Associated With Sting ActivityApplication PCTUS2017049680Pending
- Compounds And Compositions For Treating Conditions Associated With Nlrp ActivityApplication 62536352Pending
- Compounds And Compositions For Treating Conditions Associated With Nlrp ActivityApplication 62536271Pending
- NLRP3 ModulatorsApplication 62532932Pending
- Compounds And Compositions For Treating Conditions Associated With Sting ActivityApplication 62524316Pending
- NLRP3 ModulatorsApplication 62490881Pending
- Compounds And Compositions For Treating Conditions Associated With Nlrp ActivityApplication PCTUS2017028139Pending
- NLRP3 ModulatorsApplication 62460519Pending
- NLRP3 ModulatorsApplication 62460677Pending
- Compounds And Compositions For Treating Conditions Associated With Sting ActivityApplication 62436795Pending
- Compounds And Compositions For Treating Conditions Associated With Sting ActivityApplication 62436759Pending
- Compounds And Compositions For Treating Conditions Associated With Nlrp ActivityApplication 62411358Pending
- Compounds And Compositions For Treating Conditions Associated With Sting ActivityApplication 62382000Pending
- NLRP3 ModulatorsApplication 62324626Pending
- NLRP3 ModulatorsApplication 62324614Pending
- Compounds and Compositions for Treating Conditions Associated with NLRP ActivityApplication 62324071Pending
- Compounds and Compositions for Treating Conditions Associated with NLRP ActivityApplication 62324081Pending
- NLRP3 ModulatorsApplication 62573991Pending
- Compounds And Compositions For Treating Conditions Associated With Sting ActivityApplication 62277273Pending
Related companies, and why
- SunnyBay BioTech, Inc.Similar federal contract value in Biotech · null in contracts
- PROSETTA BIOCONFORMATICS INCSimilar federal contract value in Biotech · null in contracts
- Cascade Prodrug Inc.Similar federal contract value in Biotech · null in contracts
- Amide Technologies, Inc.Similar federal contract value in Biotech · null in contracts
- K36 TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Somnum Pharma, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .